FDA Relaxes Vaccine Storage Rules to Speed Up Rollout

February 26, 2021 by Daniel Mollenkamp
FDA Relaxes Vaccine Storage Rules to Speed Up Rollout
Empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas in Las Vegas. (AP Photo/John Locher)

WASHINGTON – The Food and Drug Administration has relaxed the rules around storage and transportation for some coronavirus vaccines in order to speed up the vaccine rollout.

Frozen vials of Pfizer-BioNTech’s coronavirus vaccine will be allowed to be kept at “conventional temperatures” found in pharmaceutical freezers for up to two weeks, following data provided to the agency by the company. Typically, the FDA demands that undiluted vials be stored in an ultra-low temperature freezer between -80ºC to -60ºC (-112ºF to -76ºF), a written statement from the agency said. 

This will allow for more flexibility, according to the FDA. Health care providers will receive new fact sheets to reflect this update.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said that the data Pfizer provided to the agency proves that the vaccines will remain stable at these less extreme temperatures for the two-week time period.

“The alternative temperature for transportation and storage will help ease the burden of procuring ultra-low cold storage equipment for vaccination sites and should help to get vaccines to more sites,” Marks said in a written comment.

In the U.S., 68.27 million doses of the vaccine were administered as of Thursday, Feb. 25, according to data estimates affiliated with Oxford University. An estimated 13.8% of the country, or 46.07 million people, have received at least one dose of a coronavirus vaccine. 

The Pfizer vaccine got an emergency authorization from the FDA in December. An estimate provided by the Department of Health and Human Services reported that the U.S. had purchased about $6 billion worth of Pfizer’s coronavirus vaccine as of Feb. 11.

The FDA has relaxed restrictions and oversights during the coronavirus, which has caused researchers to warn that the situation will need to be revisited after the coronavirus crisis is over to avoid the risk of weakening patient safety in the country. At the moment, however, vaccine rollout is a top priority for the agency.

A+
a-
  • FDA
  • Food and Drug Administration
  • health
  • Pfizer-BioNTech
  • supply chain
  • Transportation
  • vaccine storage
  • vaccine supply chain
  • In The News

    Health

    Voting

    Health

    What Do Weight Loss Drugs Mean for a Diet Industry Built on Eating Less and Exercising More?

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds... Read More

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept... Read More

    April 24, 2024
    by Dan McCue
    First Lady Jill Biden Salutes ‘The Power of Research’ at DC Symposium

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished... Read More

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished disbelief. Biden was second lady, the wife of Vice President Joe Biden, at the time, and Maria Shriver was the first lady of California.  Both were... Read More

    April 24, 2024
    by Dan McCue
    FDA Approves New Treatment for Urinary Tract Infections

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary... Read More

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections.  “Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Dr. Peter Kim, M.S.,... Read More

    When Red-Hot Isn't Enough: New Heat Risk Tool Sets Magenta as Most Dangerous Level

    WASHINGTON (AP) — Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to... Read More

    WASHINGTON (AP) — Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to the most dangerous conditions they may see this summer. The National Weather Service and the Centers for Disease Control and Prevention on Monday — Earth Day... Read More

    April 23, 2024
    by Dan McCue
    President Lays Out New Steps for Protecting Nation’s Waters

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’... Read More

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’ freshwater resources, including 8 million acres of wetlands and 100,000 miles of rivers and streams. Officials unveiled the plan as state, tribal and local leaders from... Read More

    April 23, 2024
    by Beth McCue
    Study Finds Next-Gen Antibiotics Underutilized

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat... Read More

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat antibiotic-resistant infections with older generic antibiotics considered to be less effective and less safe than newer ones. Researchers examined the factors influencing doctors’ preference for older... Read More

    News From The Well
    scroll top